These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34900143)

  • 1. Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780).
    Jafarzadeh S; Baharara J; Tehranipour M
    Avicenna J Med Biotechnol; 2021; 13(4):176-182. PubMed ID: 34900143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation.
    Ramezani T; Nabiuni M; Baharara J; Parivar K; Namvar F
    Iran J Pharm Res; 2019; 18(1):222-231. PubMed ID: 31089357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely low frequency electromagnetic field sensitizes cisplatin-resistant human ovarian adenocarcinoma cells via P53 activation.
    Baharara J; Hosseini N; Farzin TR
    Cytotechnology; 2016 Aug; 68(4):1403-13. PubMed ID: 26370097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
    Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines.
    Tsuruta Y; Mandai M; Konishi I; Kuroda H; Kusakari T; Yura Y; Hamid AA; Tamura I; Kariya M; Fujii S
    Eur J Cancer; 2001 Mar; 37(4):531-41. PubMed ID: 11267864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis.
    Liu Y; Cao H; Zhao Y; Shan L; Lan S
    J Ovarian Res; 2022 May; 15(1):57. PubMed ID: 35538559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells.
    Sarkhosh-Inanlou R; Molaparast M; Mohammadzadeh A; Shafiei-Irannejad V
    Chem Biol Drug Des; 2020 Feb; 95(2):215-223. PubMed ID: 31512406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
    Yang X; Zheng F; Xing H; Gao Q; Wang W; Lu Y; Wang S; Ma D
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smilax china L. rhizome extract inhibits nuclear factor-κB and induces apoptosis in ovarian cancer cells.
    Hu LL; Chen DS; Wang YY; Qin Y; Huang P; Yu LX; Liao J; Hua XL
    Chin J Integr Med; 2015 Dec; 21(12):907-15. PubMed ID: 25511428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells.
    Sundarraj K; Raghunath A; Panneerselvam L; Perumal E
    Biofactors; 2020 Jan; 46(1):118-135. PubMed ID: 31634424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance.
    Singh M; Chaudhry P; Fabi F; Asselin E
    BMC Cancer; 2013 May; 13():233. PubMed ID: 23663432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab effectively inhibit platinum-resistant ovarian cancer cells via induction of cell apoptosis and inhibition of ADAM17 expression.
    Sun LM; Liu YC; Li W; Liu S; Liu HX; Li LW; Ma R
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1198-1205. PubMed ID: 28387913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
    Muscolini M; Cianfrocca R; Sajeva A; Mozzetti S; Ferrandina G; Costanzo A; Tuosto L
    Mol Cancer Ther; 2008 Jun; 7(6):1410-9. PubMed ID: 18566213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells.
    Jiang L; Luo RY; Yang J; Cheng YX
    Mol Med Rep; 2013 Feb; 7(2):425-30. PubMed ID: 23229441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.